All pharmaceutical and biotechnology companies pursuing regulatory approvals for microbiome therapeutics and microbiome-based products are eligible for consideration of membership in MTIG.
All MTIG members must:
- Be seeking regulatory approval for at least one microbiome-based product in development
- Value strong commitment to dialogue with relevant stakeholders (including federal agencies, legislators, payors, physicians, patients, and public health officials) to improve the environment for microbiome therapeutic development
If you are interested in learning more about becoming a member of MTIG, please contact us!